Taku K - Search Results

1

[A case of jejunal neuroendocrine carcinoma complicated with dermatomyositis].

Azuma N, Satoh T, Kawaguchi S, Oshima T, Muro H, Taku K. Azuma N, et al. Among authors: taku k. Nihon Shokakibyo Gakkai Zasshi. 2018;115(12):1063-1068. doi: 10.11405/nisshoshi.115.1063. Nihon Shokakibyo Gakkai Zasshi. 2018. PMID: 30531112 Japanese.

2

[A case of poorly differentiated pancreatic adenocarcinoma with spontaneous regression wherein retrospective rim enhancement findings were important for diagnosis].

Kawaguchi S, Ohtsu T, Enokida K, Terada S, Endo S, Shirane N, Kanemoto H, Taku K, Muramatsu A. Kawaguchi S, et al. Among authors: taku k. Nihon Shokakibyo Gakkai Zasshi. 2021;118(4):358-365. doi: 10.11405/nisshoshi.118.358. Nihon Shokakibyo Gakkai Zasshi. 2021. PMID: 33840717 Japanese.

3

A long-surviving case of gastric cancer with main portal vein tumor thrombus after surgical resection and postoperative S-1 therapy.

Sato S, Nagai E, Taki Y, Watanabe M, Takahashi M, Kyoden Y, Ohata K, Kanemoto H, Oba N, Taku K, Suzuki M, Takagi M. Sato S, et al. Among authors: taku k. Clin J Gastroenterol. 2016 Aug;9(4):233-7. doi: 10.1007/s12328-016-0665-4. Epub 2016 Jun 18. Clin J Gastroenterol. 2016. PMID: 27318995

4

Survival with Cemiplimab in Recurrent Cervical Cancer.

Tewari KS, Monk BJ, Vergote I, Miller A, de Melo AC, Kim HS, Kim YM, Lisyanskaya A, Samouëlian V, Lorusso D, Damian F, Chang CL, Gotovkin EA, Takahashi S, Ramone D, Pikiel J, Maćkowiak-Matejczyk B, Guerra Alía EM, Colombo N, Makarova Y, Rischin D, Lheureux S, Hasegawa K, Fujiwara K, Li J, Jamil S, Jankovic V, Chen CI, Seebach F, Weinreich DM, Yancopoulos GD, Lowy I, Mathias M, Fury MG, Oaknin A; Investigators for GOG Protocol 3016 and ENGOT Protocol En-Cx9. Tewari KS, et al. N Engl J Med. 2022 Feb 10;386(6):544-555. doi: 10.1056/NEJMoa2112187. N Engl J Med. 2022. PMID: 35139273 Clinical Trial.

5

Submucosal tumor appearance is a useful endoscopic predictor of early primary-site recurrence after definitive chemoradiotherapy for esophageal squamous cell carcinoma.

Tu CH, Muto M, Horimatsu T, Taku K, Yano T, Minashi K, Onozawa M, Nihei K, Ishikura S, Ohtsu A, Yoshida S. Tu CH, et al. Among authors: taku k. Dis Esophagus. 2011 May;24(4):274-8. doi: 10.1111/j.1442-2050.2010.01141.x. Epub 2010 Nov 18. Dis Esophagus. 2011. PMID: 21087347 Free article.

6

Irinotecan plus cisplatin therapy and S-1 plus cisplatin therapy for advanced or recurrent gastric cancer in a single institution.

Nakashima K, Hironaka S, Boku N, Onozawa Y, Fukutomi A, Yamazaki K, Yasui H, Taku K, Kojima T, Machida N. Nakashima K, et al. Among authors: taku k. Jpn J Clin Oncol. 2008 Dec;38(12):810-5. doi: 10.1093/jjco/hyn109. Epub 2008 Nov 6. Jpn J Clin Oncol. 2008. PMID: 18988666

7

Weekly paclitaxel for heavily treated advanced or recurrent gastric cancer refractory to fluorouracil, irinotecan, and cisplatin.

Shimoyama R, Yasui H, Boku N, Onozawa Y, Hironaka S, Fukutomi A, Yamazaki K, Taku K, Kojima T, Machida N, Todaka A, Tomita H, Sakamoto T, Tsushima T. Shimoyama R, et al. Among authors: taku k. Gastric Cancer. 2009;12(4):206-11. doi: 10.1007/s10120-009-0524-9. Epub 2010 Jan 5. Gastric Cancer. 2009. PMID: 20047125

8

Activity of S-1 in advanced or recurrent gastric cancer patients after failure of prior chemotherapy, including irinotecan + cisplatin or fluorouracil (except S-1).

Ono A, Boku N, Onozawa Y, Hironaka S, Fukutomi A, Yasui H, Yamazaki K, Yoshino T, Taku K, Kojima T. Ono A, et al. Among authors: taku k. Jpn J Clin Oncol. 2009 May;39(5):332-5. doi: 10.1093/jjco/hyp018. Epub 2009 Mar 24. Jpn J Clin Oncol. 2009. PMID: 19318372

9

A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2).

Kato K, Satoh T, Muro K, Yoshikawa T, Tamura T, Hamamoto Y, Chin K, Minashi K, Tsuda M, Yamaguchi K, Machida N, Esaki T, Goto M, Komatsu Y, Nakajima TE, Sugimoto N, Yoshida K, Oki E, Nishina T, Tsuji A, Fujii H, Kunieda K, Saitoh S, Omuro Y, Azuma M, Iwamoto Y, Taku K, Fushida S, Chen LT, Kang YK, Boku N. Kato K, et al. Among authors: taku k. Gastric Cancer. 2019 Mar;22(2):344-354. doi: 10.1007/s10120-018-0899-6. Epub 2018 Dec 1. Gastric Cancer. 2019. PMID: 30506519 Free PMC article. Clinical Trial.

10

Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G).

Yamazaki K, Nagase M, Tamagawa H, Ueda S, Tamura T, Murata K, Eguchi Nakajima T, Baba E, Tsuda M, Moriwaki T, Esaki T, Tsuji Y, Muro K, Taira K, Denda T, Funai S, Shinozaki K, Yamashita H, Sugimoto N, Okuno T, Nishina T, Umeki M, Kurimoto T, Takayama T, Tsuji A, Yoshida M, Hosokawa A, Shibata Y, Suyama K, Okabe M, Suzuki K, Seki N, Kawakami K, Sato M, Fujikawa K, Hirashima T, Shimura T, Taku K, Otsuji T, Tamura F, Shinozaki E, Nakashima K, Hara H, Tsushima T, Ando M, Morita S, Boku N, Hyodo I. Yamazaki K, et al. Among authors: taku k. Ann Oncol. 2016 Aug;27(8):1539-46. doi: 10.1093/annonc/mdw206. Epub 2016 May 13. Ann Oncol. 2016. PMID: 27177863 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters